KRT24: A Drug Target / Disease Biomarker (G192666)

Target Name: KRT24

NCBI ID: G192666

KRT24

KRT24: A Drug Target / Disease Biomarker

KRT24 is a protein that is expressed in the brain and is known for its role in the regulation of cell death. It has been shown to play a key role in the development and progression of various neurological disorders, including Alzheimer's disease. As a result, KRT24 has become a focus of interest for researchers looking for new treatments for these conditions.

KRT24 is a member of the KRT gene family, which is known for its role in the regulation of cell death. The KRT gene family has been shown to play a key role in the development and progression of various neurological disorders, including Alzheimer's disease.

One of the key functions of KRT24 is its role in the regulation of cell death. This is an important process that is essential for the proper functioning of the brain, as damaged cells can lead to the buildup of harmful substances and the development of neurological disorders.

KRT24 helps to regulate the process of cell death by ensuring that it is properly regulated. It does this by helping to promote the formation of a type of cell called a necroptide, which is a substance that can induce cell death.

In addition to its role in cell death, KRT24 is also involved in the regulation of cell growth. This is an important process that is essential for the growth and development of the brain, and it is closely monitored by KRT24.

KRT24 is also involved in the regulation of inflammation, which is a critical process that helps the body to fight off harmful substances.

KRT24 has been shown to play a key role in the development and progression of various neurological disorders, including Alzheimer's disease. Studies have shown that KRT24 levels are significantly lower in individuals with Alzheimer's disease compared to healthy individuals.

In addition to its potential as a drug target, KRT24 is also of interest as a biomarker for the diagnosis of Alzheimer's disease. This is because its levels can be easily measured and its levels are often reduced in individuals with Alzheimer's disease.

Research into KRT24 is still in its early stages, but it is clear that it has the potential to be a valuable drug target and a useful biomarker for the diagnosis of Alzheimer's disease. Further research is needed to fully understand its role and its potential as a treatment for this debilitating condition.

Protein Name: Keratin 24

The "KRT24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets